quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:00:00·46d
NEWSRelease
Jaguar Health Inc. logo

Jaguar Health Strengthens Company's Balance Sheet by Restructuring and Reducing Royalty and Debt Obligations and Extinguishing Warrants

JAGX· Jaguar Health Inc.
Health Care
Original source

Companies

  • JAGX
    Jaguar Health Inc.
    Health Care

Recent analyst ratings

  • Jul 7UpdateCantor Fitzgerald$5.00

Related

  • NEWS2h
    Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN)
  • SEC3d
    SEC Form PRE 14A filed by Jaguar Health Inc.
  • SEC3d
    SEC Form 8-K filed by Jaguar Health Inc.
  • NEWS3d
    Jaguar Health Reports Approval of All Proposals at April 2026 Special Meeting of Stockholders
  • NEWS11d
    Artificial Intelligence (AI) Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs
  • NEWS14d
    Reminder: Jaguar Health to Host Investor Webcast at 8:30 am Eastern on Friday, April 10, 2026 Regarding Q4 2025 Financials and Company Updates
  • SEC14d
    SEC Form 8-K filed by Jaguar Health Inc.
  • NEWS16d
    Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022